GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 37.94
+2.96 (8.46%)
At close: Sep 30, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 15.52 billion as of October 2, 2026. Its market cap has increased by 114.92% in one year.
Market Cap
15.52B
Enterprise Value
14.60B
Revenue
878.13M
Ranking
n/a
PE Ratio
84.01
Stock Price
37.94
ChartMarket Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 15.52B, an increase of 104.66%. That is a compound annual growth rate of 17.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 15.52B | 146.50% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 19.34B |
| Yili Chuanning Biotechnology | 18.28B |
| HitGen | 17.91B |
| Sinocelltech Group | 17.43B |
| BrightGene Bio-Medical Technology | 15.59B |
| Anhui Anke Biotechnology (Group) | 14.35B |
| Shanghai Medicilon | 14.16B |
| Nanjing Vazyme Biotech | 14.08B |